Observation of effects of body fluids on indicator cells for disease diagnosis

• US 20030195431A1
• Filed: 04/10/2002
• Published: 10/16/2003
• Est. Priority Date: 04/10/2002
• Status: Abandoned Application

• Current Assignee: Vikas P. Sukhatme
• Original Assignee: Vikas P. Sukhatme
• Inventors: Sukhatme, Vikas P.
• Application Number:
  US10/120,022
• Publication Number:
  US 20030195431A1
• Time in Patent Office: Days
• US Class Current: 600/562
• CPC Class Codes: A61B 10/0045 Devices for taking samples of body liquids devices for taking blood samples A61B5/15
• CPC Class Codes: G01N 2800/52 Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
• CPC Class Codes: G01N 33/5091 for testing the pathological state of an organism

Abstract

The invention features methods of obtaining information regarding a health parameter of a patient, in which a cell-free body fluid is incubated with an indicator cell and changes in the indicator cell, such as an increase or decrease in gene expression are observed.

Claims

1. A method of obtaining information regarding a health parameter of a patient, said method comprising the steps of:

a) obtaining a sample of a body fluid from said patient;

b) ensuring that said sample is substantially cell-free;

c) incubating said sample with a cell; and

d) determining or measuring a property of said cell following incubation.

2. The method of claim 1, wherein step d) comprises determining the level of expression of one or more genes in said cell.

3. The method of claim 1, further comprising the steps of:

e) repeating steps a)-d) at a second time point; and

f) comparing the results of step d) for the two time points.

4. The method of claim 3, wherein the first sample is obtained prior to treatment of the patient for a medical disorder, and the second sample is obtained from the patient following treatment.

5. The method of claim 2, wherein step d) involves determining the level of expression of multiple genes in said cell.

6. A method of obtaining information regarding a health parameter of a patient, said method comprising the steps of:

a) obtaining a sample of a body fluid from said patient;

b) ensuring that said sample is substantially cell-free;

c) incubating said sample with a genetically engineered cell comprising a molecule that is responsive to a substance whose presence or absence in a body fluid is associated with a disease state; and

d) determining the response of said responsive molecule of said engineered cell to incubation with said body fluid.

7. The method of claim 6, wherein said responsive molecule is a receptor.

8. The method of claim 6, wherein said responsive molecule is a transcription factor.

9. The method of claim 6, wherein said responsive molecule is associated with a reporter molecule.

10. A method of making a disease-specific array (DSA) for use in the diagnosis or monitoring of a pre-determined disease, said method comprising the steps of:

a) obtaining a sample of a substantially cell-free body fluid from a patient suffering from said disease,

b) incubating said sample with a cell,

c) determining the level of expression of multiple genes in said cell following incubation.

d) comparing the information obtained in step c) with the expression level of multiple genes observed when the same cell type is incubated, under the same conditions, using a matched sample of the same body fluid obtained from a person suffering from said disease, to identify one or more genes that are expressed at different levels in the two samples, and

e) incorporating the genes identified in step d), or RNA molecules corresponding to said genes, or fragments of said genes, into or onto a carrier to form said DSA.

11. A DSA formed by the process of claim 10.

12. A method of obtaining a gene expression signature specific for a predetermined disease, said method comprising the steps of:

a) obtaining a sample of substantially cell-free body fluid from a patient suffering from said disease,

b) incubating said sample with a cell, and

c) determining the level of expression of multiple genes following incubation, such determination constituting said disease-specific signature.